Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Svetlana Dey Insider Profile
4 Followers
Svetlana Dey, Director at Bluejay Diagnostics, holds 206.07K shares in Bluejay Diagnostics (Ticker: BJDX). Most recently, Svetlana Dey Bought $500 shares of Bluejay Diagnostics on Dec 14, 2023 for an estimated value of 1.53K.
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-81.30%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Svetlana Dey holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 21, 2022 - Mar 21, 2023
Return:-63.10%
The most profitable trade made by Svetlana Dey
Svetlana Dey's Trading History
List of latest transactions for each holding click on a transaction to see Svetlana Dey's performance on stock
You May Also Like
Svetlana Dey insider profile FAQ
What is the percentage of profitable transactions made by Svetlana Dey?
The percentage of profitable transactions made by Svetlana Dey is 0%.
What is the average return per transaction made by Svetlana Dey?
The average return per transaction made by Svetlana Dey is -81.30%.
What stocks does Svetlana Dey hold?
Svetlana Dey holds: BJDX stocks.
What was Svetlana Dey’s latest transaction?
Svetlana Dey latest transaction was an Informative Buy of $1.53K.
What was Svetlana Dey's most profitable transaction?
Svetlana Dey’s most profitable transaction was an Informative Buy of BJDX stock on March 21, 2022. The return on the trade was -63.10%.
What is Svetlana Dey's role in Bluejay Diagnostics?
Svetlana Dey's role in Bluejay Diagnostics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.